Why the Low-Pressure Glaucoma Treatment Study makes sense

Expert Review of Ophthalmology

Volumn 7, Issue 4, 2012, Pages 295-297

  Pasquale, Louis R ^a   Feke, Gilbert ^a   Harris, Alon ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

brimonidine; disc hemorrhage; nitric oxide; retinal vascular autoregulation; the Low Pressure Glaucoma Treatment Study

Indexed keywords

BRIMONIDINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; TIMOLOL;

COMPARATIVE EFFECTIVENESS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG USE; GENE; GLAUCOMA; HEMODYNAMICS; HUMAN; INTRAOCULAR HEMORRHAGE; INTRAOCULAR PRESSURE; NITRIC OXIDE SYNTHASE 3 GENE; OPEN ANGLE GLAUCOMA; RETINA BLOOD FLOW; REVIEW; SIGNAL TRANSDUCTION; UNSPECIFIED SIDE EFFECT; VISUAL FIELD;

EID: 84866916378     PISSN: 17469899     EISSN: 17469902     Source Type: Journal    
DOI: 10.1586/eop.12.36     Document Type: Review

References (22)

1. Budenz DL, Anderson DR, Feuer WJ et al.; Ocular Hypertension Treatment Study Group. Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study. Ophthalmology 113(12), 2137-2143 (2006). (Pubitemid 44838922)
2. Anderson DR; Normal Tension Glaucoma Study. Collaborative normal tension glaucoma study. Curr. Opin. Ophthalmol. 14(2), 86-90 (2003). (Pubitemid 36584227)
3. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E; Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: The early manifest glaucoma trial. Arch. Ophthalmol. 121(1), 48-56 (2003). (Pubitemid 36401765)
4. Medeiros FA, Zangwill LM, Alencar LM, Sample PA, Weinreb RN. Rates of progressive retinal nerve fiber layer loss in glaucoma measured by scanning laser polarimetry. Am. J. Ophthalmol. 149(6), 908-915 (2010).
5. Miyake T, Sawada A, Yamamoto T, Miyake K, Sugiyama K, Kitazawa Y. Incidence of disc hemorrhages in open-angle glaucoma before and after trabeculectomy. J. Glaucoma 15(2), 164-171 (2006).
6. Hendrickx KH, van den Enden A, Rasker MT, Hoyng PF. Cumulative incidence of patients with disc hemorrhages in glaucoma and the effect of therapy. Ophthalmology 101(7), 1165-1172 (1994). (Pubitemid 24236072)
7. Krupin T, Liebmann JM, Greenfield DS, Ritch R, Gardiner S; Low-Pressure Glaucoma Study Group. A randomized trial of brimonidine versus timolol in preserving visual function: Results from The Low- Pressure Glaucoma Treatment Study. Am. J. Ophthalmol. 151(4), 671-681 (2011).
8. Feke GT, Pasquale LR. Retinal blood flow response to posture change in glaucoma patients compared with healthy subjects. Ophthalmology 115(2), 246-252 (2008). (Pubitemid 351163367)
9. Kang JH, Wiggs JL, Haines J, Abdrabou W, Pasquale LR. Reproductive factors and NOS3 variant interactions in primary openangle glaucoma. Mol. Vis. 17, 2544-2551 (2011).
10. Kang JH, Wiggs JL, Rosner BA, Haines J, Abdrabou W, Pasquale LR. Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: Interactions with hypertension, alcohol intake, and cigarette smoking. Arch. Ophthalmol. 129(6), 773-780 (2011).
11. Kang JH, Wiggs JL, Rosner BA et al. Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: Interactions with sex and postmenopausal hormone use. Invest. Ophthalmol. Vis. Sci. 51(2), 971-979 (2010).
12. Rosa RH Jr, Hein TW, Yuan Z et al. Brimonidine evokes heterogeneous vasomotor response of retinal arterioles: Diminished nitric oxide-mediated vasodilation when size goes small. Am. J. Physiol. Heart Circ. Physiol. 291(1), H231-H238 (2006).
13. Kent AR, King L, Bartholomew LR. Vitreous concentration of topically applied brimonidine-purite 0.15%. J. Ocul. Pharmacol. Ther. 22(4), 242-246 (2006). (Pubitemid 44689663)
14. Kent AR, Nussdorf JD, David R, Tyson F, Small D, Fellows D. Vitreous concentration of topically applied brimonidine tartrate 0.2%. Ophthalmology 108(4), 784-787 (2001). (Pubitemid 32238477)
15. Feke GT, Hazin R, Grosskreutz CL, Pasquale LR. Effect of brimonidine on retinal blood flow autoregulation in primary open-angle glaucoma. J. Ocul. Pharmacol. Ther. 27(4), 347-352 (2011).
16. Takayama K, Hangai M, Kimura Y et al. Abnormal lesions of the lamina cribrosa in eyes with glaucoma visualized using Sweptsource optical coherence tomogrpahy. Invest. Ophth. Vis. Sci. 2816/A145 (2012).
17. Potter GM, Marlborough FJ, Wardlaw JM. Wide variation in definition, detection, and description of lacunar lesions on imaging. Stroke 42(2), 359-366 (2011).
18. Bergstrand IC, Heijl A, Wollmer P, Hansen F, Harris A. Timolol increased retrobulbar flow velocities in untreated glaucoma eyes but not in ocular hypertension. Acta Ophthalmol. Scand. 79(5), 455-461 (2001). (Pubitemid 32962833)
19. Rahman MQ, Abeysinghe SS, Kelly S et al. Persistence of glaucoma medical therapy in the Glasgow Glaucoma Database. Br. J. Ophthalmol. 95(7), 966-970 (2011).
20. Quaranta L, Gandolfo F, Turano R et al. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma. Invest. Ophthalmol. Vis. Sci. 47(7), 2917-2923 (2006). (Pubitemid 351639767)
21. Bengtsson B, Holmin C, Krakau CE. Disc haemorrhage and glaucoma. Acta Ophthalmol. (Copenh.) 59(1), 1-14 (1981). (Pubitemid 11191167)
22. Healey PR, Mitchell P, Smith W, Wang JJ. Optic disc hemorrhages in a population with and without signs of glaucoma. Ophthalmology 105(2), 216-223 (1998). (Pubitemid 28090823)